{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:01:32Z","timestamp":1792119692630,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1038\/jid.2014.270","type":"journal-article","created":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T13:49:03Z","timestamp":1404740943000},"page":"2957-2966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Promoter CpG Island Hypermethylation in Dysplastic Nevus and Melanoma: CLDN11 as an Epigenetic Biomarker for Malignancy"],"prefix":"10.1016","volume":"134","author":[{"given":"Linda","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"van den Hurk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.M.","family":"Moerkerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle J.","family":"Goeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelleke A.","family":"Gruis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost J.","family":"van den Oord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique J.","family":"Winnepenninckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"van Engeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2014.270_bb0010","doi-asserted-by":"crossref","first-page":"e8002","DOI":"10.1371\/journal.pone.0008002","article-title":"Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells","volume":"4","author":"Agarwal","year":"2009","journal-title":"PLoS One"},{"key":"10.1038\/jid.2014.270_bb0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-2407-7-196","article-title":"Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis","volume":"7","author":"Arabzadeh","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1038\/jid.2014.270_bb0020","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/01.MP.0000082394.91761.E5","article-title":"Grading of atypia in nevi: correlation with melanoma risk","volume":"16","author":"Arumi-Uria","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1038\/jid.2014.270_bb0025","first-page":"1503","article-title":"Claudin-11 decreases the invasiveness of bladder cancer cells","volume":"25","author":"Awsare","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1038\/jid.2014.270_bb0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1034\/j.1600-0749.2003.00047.x","article-title":"Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data","volume":"16","author":"Bauer","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1038\/jid.2014.270_bb0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/gcc.20615","article-title":"Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma","volume":"48","author":"Bonazzi","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/jid.2014.270_bb0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/path.1061","article-title":"Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions","volume":"196","author":"Brochez","year":"2002","journal-title":"J Pathol"},{"key":"10.1038\/jid.2014.270_bb0045","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/path.4011","article-title":"Epigenetic disruption of cadherin-11 in human cancer metastasis","volume":"228","author":"Carmona","year":"2012","journal-title":"J Pathol"},{"key":"10.1038\/jid.2014.270_bb0050","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0046-8177(84)80310-X","article-title":"A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma","volume":"15","author":"Clark","year":"1984","journal-title":"Hum Pathol"},{"key":"10.1038\/jid.2014.270_bb0055","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1755-148X.2011.00828.x","article-title":"DNA-methylation profiling distinguishes malignant melanomas from benign nevi","volume":"24","author":"Conway","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1038\/jid.2014.270_bb0060","doi-asserted-by":"crossref","first-page":"e70062","DOI":"10.1371\/journal.pone.0070062","article-title":"A novel tumor suppressor function of glycine N-methyltransferase is independent of its catalytic activity but requires nuclear localization","volume":"8","author":"DebRoy","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/jid.2014.270_bb0065","first-page":"291","article-title":"Methylation-specific PCR unraveled","volume":"26","author":"Derks","year":"2004","journal-title":"Cell Oncol"},{"key":"10.1038\/jid.2014.270_bb0070","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2559.2009.03450.x","article-title":"Dysplastic naevi: an update","volume":"56","author":"Elder","year":"2010","journal-title":"Histopathology"},{"key":"10.1038\/jid.2014.270_bb0075","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1038\/jid.2014.270_bb0080","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/pcmr.12096","article-title":"Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma","volume":"26","author":"Gao","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1038\/jid.2014.270_bb0085","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/PAS.0b013e3181ba6db6","article-title":"Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi","volume":"33","author":"Gerami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/jid.2014.270_bb0090","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/jid.2011.380","article-title":"RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi","volume":"132","author":"Helmbold","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.270_bb0095","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","article-title":"Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands","volume":"93","author":"Herman","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2014.270_bb0100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00109-013-1010-8","article-title":"A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma","volume":"91","author":"Huidobro","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"10.1038\/jid.2014.270_bb0105","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1073\/pnas.0901185106","article-title":"A multi-marker assay to distinguish malignant melanomas from benign nevi","volume":"106","author":"Kashani-Sabet","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2014.270_bb0110","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1038\/onc.2011.541","article-title":"The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt\/beta-catenin signaling and silenced in common carcinomas","volume":"31","author":"Li","year":"2012","journal-title":"Oncogene"},{"key":"10.1038\/jid.2014.270_bb0115","doi-asserted-by":"crossref","first-page":"e1000923","DOI":"10.1371\/journal.pgen.1000923","article-title":"Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death","volume":"6","author":"Marchong","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1038\/jid.2014.270_bb0120","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMcp023017","article-title":"Dysplastic nevi","volume":"349","author":"Naeyaert","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2014.270_bb0125","doi-asserted-by":"crossref","first-page":"322S","DOI":"10.1038\/jid.1993.56","article-title":"Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness","volume":"100","author":"Sagebiel","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.270_bb0130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1470-2045(06)70847-6","article-title":"New prediction model for melanoma","volume":"7","author":"Sharma","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1038\/jid.2014.270_bb0135","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaad.2009.09.043","article-title":"Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center","volume":"62","author":"Shoo","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2014.270_bb0140","first-page":"89","article-title":"Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune","volume":"1826","author":"van den Hurk","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/jid.2014.270_bb0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2133.2006.07570.x","article-title":"Melanomas arising from naevi and de novo melanomas\u2014does origin matter?","volume":"156","author":"Weatherhead","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2014.270_bb0150","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jnci\/djj103","article-title":"Gene expression profiling of primary cutaneous melanoma and clinical outcome","volume":"98","author":"Winnepenninckx","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/jid.2014.270_bb0155","doi-asserted-by":"crossref","first-page":"e45037","DOI":"10.1371\/journal.pone.0045037","article-title":"Novel multiple markers to distinguish melanoma from dysplastic nevi","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15365805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15365805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T21:13:05Z","timestamp":1743973985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15365805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0022202X15365805"],"URL":"https:\/\/doi.org\/10.1038\/jid.2014.270","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promoter CpG Island Hypermethylation in Dysplastic Nevus and Melanoma: CLDN11 as an Epigenetic Biomarker for Malignancy","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2014.270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}